Home
Conditions
Lymphoma, Follicular

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Completed

Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma

NCT01701232

Conditions: Follicular Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Instituto Nacional de Cancerología Bogotá, Colombia

Fundación Reina Isabel Cali, Colombia

Hospital Pablo Tobon Uribe Medellín, Colombia

HCG Multi Specialty Hospitals Ahmedabad, India

View all 62 locations

View Trial Details

Completed

Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00425802

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

NCT01311232

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
Locations: Queen Mary Hospital Hing Kong, China

Hospital Kuala Lumpur Kuala Lumpur, Malaysia

National Cancer Center Singapore

Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

A Safety Study of SGN-CD19A for B-Cell Lymphoma

NCT01786135

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope National Medical Center Duarte, California, United States

Stanford Cancer Center Stanford, California, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma

NCT01239394

Conditions: Chronic Disease, Disease Attributes, Follicular Lymphoma, +21 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00301951

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +55 more
Locations: UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

NCT01682044

Conditions: Chronic Disease, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, +51 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00245037

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

NCT00238433

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +37 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Lymphoma, Follicular

Lymphoma, Follicular trial results

Related conditions